Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain ...Middle East

- EMERALD Study will investigate the safety and efficacy of RTX001, an engineered macrophage cell therapy, in patients with end-stage liver disease - Recruitment already underway in the U.K., following recent MHRA approval EDINBURGH, Scotland and LONDON, Nov. 19, 2024 /PRNewswire/ --...

Read More Details
Finally We wish PressBee provided you with enough information of ( Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain )

Also on site :

• Taylor Swift and Travis Kelce break cover after being spotted on date night close to $20 million love bunker
• '90s 'Dawson's Creek' Heartthrob, 53, Nearly Unrecognizable in 'Van Life' Video
• Six people wounded, one critically, in mass shooting in Colorado Springs